MRNA dominated market conversation this week. Moderna's cancer vaccine breakthrough sent shares up 177%. Short sellers who held 13.5% of free float faced an immediate squeeze threat. Availability sits at 279% of SI — meaning there are still shares to borrow. But at this pace, that may not last.
RDDT is a fresh mover to watch. Short interest jumped 4.2 percentage points in seven days. It now sits at 17.9% of free float. Reddit is a social platform that short sellers discuss on social platforms. The irony is not lost on traders.
WOLF remains the most shorted name in the mid-cap universe. SI hit 86.5% of free float. Bears added another 5.5 points in the past week. Availability is zero — no shares left to borrow. The chip maker's stock fell 47% over three months. Short sellers clearly see more downside.
EVCM carries the highest short score at 93.5. Cost to borrow is a steep 39.2% APR. Days to cover stretches nearly 20 days. That combination makes any positive catalyst dangerous for shorts.
NVIDIA earnings loom this week. ORTEX data shows bears and insiders are actively repositioning around NVDA. That sets up a volatile print. also drew short-seller attention ahead of its upcoming results.
REPL surged 231% over three months yet short interest climbed 3 points to 40.4% of free float. Shorts are doubling down against the biotech rally. It is a bold bet.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
